Premarket Evidence Development
Premarket Evidence Development is a systematic process within regulatory science that generates empirical data and analytical justifications to demonstrate the safety, efficacy, and performance of a medical device prior to market authorization, distinguishing it from postmarket surveillance by focusing on pre-commercialization validation requirements under frameworks such as Investigational Device Exemptions.
10
Publications
256
Citations
43
Authors
30
Institutions
Publications per year
2017–2026
7
10
Rosanna Tarricone, Helen Banks, Oriana Ciani et al. · Expert Review of Medical Devices · 2023 · 23 citations · Full text
1–5 of 10
43
2
h-index
2
h-index
1
h-index
1
h-index
1
h-index
1–5 of 43
30
Yale University
New Haven, United States
2 h-index
4 publications
187 citations

Bocconi University
Milan, Italy
1 h-index
3 publications
69 citations
Assistance Publique – Hôpitaux de Paris
Paris, France
1 h-index
1 publications
23 citations
University of Redlands
Redlands, United States
1 h-index
1 publications
23 citations
Hôpital Européen
Marseille, France
1 h-index
1 publications
23 citations
University of California, San Francisco
San Francisco, United States
1 h-index
2 publications
20 citations
Erasmus University Rotterdam
Rotterdam, The Netherlands
1 h-index
1 publications
23 citations
Hôpital Européen Georges-Pompidou
Paris, France
1 h-index
1 publications
23 citations
1–8 of 30
2 publications · 63 citations
2
h-index
1 publications · 11 citations
1
h-index
NEJM · 1 publications · 34 citations
1
h-index
1 publications · 23 citations
1
h-index
1 publications · 59 citations
1
h-index
1–5